Clinical Trials

Lung Neoplasms

NCT06295497 2026-03-18

Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device

3,000 enrolled

Lung Neoplasms

NCT06328621 2026-03-18

Lung Cancer Risk Assessment and Etiology

Completed

109 enrolled

Lung Neoplasms

NCT06618599 2026-03-18

Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block

60 enrolled

Lung Neoplasms

NCT06682013 2026-03-18

Virtual Agent Feasibility in Oncology Patients (NTT Data)

36 enrolled

Lung Neoplasms

NCT07163507 2026-03-18

RICEPS-2

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05456841 2026-03-17

Empathic Communication Skills (ECS) Training

1,232 enrolled

Lung Neoplasms

NCT06213532 2026-03-17

CONNECTing to LungCare

147 enrolled

Lung Neoplasms, Smoking Cessation

NCT07040618 2026-03-17

RIB-ESPB

60 enrolled

Lung Neoplasms

NCT07396467 2026-03-17

IPF-LC-IO

Active not recruiting

200 enrolled

Disease, Lung Neoplasms, Pulmonary Fibrosis, Lung Diseases, Interstitial

NCT07476495 2026-03-17

LUCID

Recruiting

100 enrolled

Lung Neoplasms, Neoplasms

NCT07477158 2026-03-17

Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer.

Recruiting

180 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07478276 2026-03-17

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

84 enrolled

Treatment Adherence and Compliance, Lung Neoplasms, Motor Activity

NCT07478757 2026-03-17

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

15,000 enrolled

Lung Neoplasms

NCT01647425 2026-03-16

ALTAK

Completed

385 enrolled

Head & NeckThoracic

Alcoholism, Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use Disorder

NCT04499053 2026-03-16

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

Phase 2 Recruiting

18 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06070870 2026-03-16

HEALS

675 enrolled

Lung Neoplasms

NCT06538038 2026-03-16

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Recruiting

538 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06660407 2026-03-16

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase 2 Recruiting

20 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07472478 2026-03-16

GIVEN

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02540174 2026-03-13

ALTAKRA-1405

Phase NA Completed

133 enrolled

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use

NCT07176000 2026-03-13

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

237 enrolled

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07322341 2026-03-13

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04919382 2026-03-12

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Phase 2 Recruiting

56 enrolled